Literature DB >> 7740495

Tissue factor activity of syncytiotrophoblast plasma membranes and tumoral trophoblast cells in culture.

P Reverdiau1, A C Jarousseau, G Thibault, B Khalfoun, H Watier, Y Lebranchu, P Bardos, Y Gruel.   

Abstract

During pregnancy, important modifications of hemostasis occur resulting in mothers in hypercoagulability and the role of placental cells such as trophoblast cells has been hypothesized. In this study, we first showed that syncytiotrophoblast plasma membranes, isolated from normal human placenta, expressed a strong tissue factor (TF) activity. We then studied TF activity of two continuous trophoblast cell lines (JEG-3 and BeWo) in comparison to human umbilical vein endothelial cells (HUVEC) and transformed human endothelial cells (ECV-304). TF assays were performed on intact detached confluent cells. Unstimulated JEG-3 and BeWo cells exhibited a very high TF activity which slightly increased after 2 to 4 h TNF-alpha stimulation. In contrast, HUVEC and ECV-304 had a lower basal TF activity which was mainly inducible by TNF-alpha, with a maximum effect after 4 to 6 h stimulation. For both cell types, TF activity was decreased to basal value after 16-hour TNF-alpha stimulation. These results support that trophoblast cells are able to express TF but the involvement of this property in the hemostatic physiological changes observed during pregnancy, remains to be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7740495

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells.

Authors:  Rashmi Sood; Shawn Kalloway; Alan E Mast; Cecilia J Hillard; Hartmut Weiler
Journal:  Blood       Date:  2005-12-27       Impact factor: 22.113

Review 2.  DIC in Pregnancy - Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments.

Authors:  Offer Erez; Maha Othman; Anat Rabinovich; Elad Leron; Francesca Gotsch; Jecko Thachil
Journal:  J Blood Med       Date:  2022-01-06

3.  Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability.

Authors:  Robert A Campbell; Katherine A Overmyer; Craig H Selzman; Brett C Sheridan; Alisa S Wolberg
Journal:  Blood       Date:  2009-10-01       Impact factor: 22.113

4.  Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity.

Authors:  Chris Gardiner; Dionne S Tannetta; Carol A Simms; Paul Harrison; Christopher W G Redman; Ian L Sargent
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

Review 5.  Extracellular vesicles and reproduction-promotion of successful pregnancy.

Authors:  Dionne Tannetta; Rebecca Dragovic; Zahraa Alyahyaei; Jennifer Southcombe
Journal:  Cell Mol Immunol       Date:  2014-06-23       Impact factor: 11.530

Review 6.  Prothrombotic state associated with preeclampsia.

Authors:  Cha Han; Yuan-Yuan Chen; Jing-Fei Dong
Journal:  Curr Opin Hematol       Date:  2021-09-01       Impact factor: 3.218

Review 7.  Placental disease and the maternal syndrome of preeclampsia: missing links?

Authors:  Dionne Tannetta; Ian Sargent
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.